Skip to main content
. 2015 Jun;150:54–63. doi: 10.1016/j.jsbmb.2015.03.010

Fig. 1.

Fig. 1

Immunolocalization of Aromatase (A, F, K, P), STS (B, G, L, Q), EST (C, H, M, R), 17BHSD2 (D, I, N, S) and 17BHSD5 (E, J, O, T) proteins in pre-menopausal (A–E), post-menopausal (F–J) ovaries and epithelial ovarian cancer (K–T). Expression was localized using specific antibodies raised against Aromatase, STS, EST, 17BHSD2 and 17BHSD5, as described in Section 2. Examples shown are representative of 3 pre-menopausal, 6 post-menopausal and 7 EOC patient samples. The clinicopathalogical profiles of the samples are given in Supplementary Tables 1 and 3. (K–O) Aromatase, STS, EST, 17BHSD2 and 17BHSD5 in high grade serous carcinoma, (P) Aromatase in endometrioid carcinoma grade 3, (Q) STS in a mixed high grade serous and endometrioid carcinoma, (R) EST in endometrioid carcinoma grade 3, (S) 17BHSD2 in endometrioid carcinoma grade 3, (T) 17BHSD5 in mixed high grade serous and endometrioid carcinoma. Arrow indicates OSE cells (A–J) or epithelial-like cells (K–T). Asterisk marks stromal tissue. Inserts show positive control-placenta (A) or non-immune serum controls (C, G, S, T). Scale bars 40 μm.